News

Metformin May Lower Pancreatic Cancer Risk in Women


 

FROM THE AMERICAN JOURNAL OF GASTROENTEROLOGY

"Although uncontrolled confounding by dietary habits or physical activity may be of importance, these findings do not support a causative role for diabetes mellitus for development of pancreatic cancer," they noted.

This study was partially funded by the Swiss Cancer League and the Research Fund of the University of Basel, Switzerland. None of the authors had relevant disclosures.

Pages

Recommended Reading

Obesity, Estrogen Status Influence Breast Cancer Outcomes
MDedge Hematology and Oncology
FDA Adds Bladder Cancer Risk Warning to Pioglitazone
MDedge Hematology and Oncology
Global Change Needed to Stem Obesity Pandemic
MDedge Hematology and Oncology
Bisphosphonate Cancer Risk Divides FDA Officials
MDedge Hematology and Oncology
FDA Panel: Update Bisphosphonate Labeling
MDedge Hematology and Oncology
UN Adopts Noncommunicable Disease Declaration
MDedge Hematology and Oncology
Obesity May Explain Liver Cancer Hike Among Latinos
MDedge Hematology and Oncology
Possible Cancer Link to Diabetes Drugs Stirs Controversy
MDedge Hematology and Oncology
Recent Diabetes Increases Breast Cancer Risk
MDedge Hematology and Oncology